Congenital erythropoietic porphyria: Characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 748-756

  Bishop, David F ^a   Clavero, Sonia ^a   Mohandas, Narla ^b   Desnick, Robert J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PORPHYRIN; UROPORPHYRINOGEN III SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD SMEAR; BODY WEIGHT; CONGENITAL ERYTHROPOIETIC PORPHYRIA; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HOMOZYGOSITY; IRON DEFICIENCY ANEMIA; LEUKOCYTE; LIVER WEIGHT; MALE; MICROCYTOSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE; RETICULOCYTOSIS; SPLEEN WEIGHT;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FEMALE; GENOTYPE; HUMANS; KIDNEY; LIVER; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; PHENOTYPE; PORPHYRIA, ERYTHROPOIETIC; PORPHYRINS; SPLEEN; TIME FACTORS; UROPORPHYRINOGEN III SYNTHETASE;

EID: 79960723476     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00258     Document Type: Article

References (36)

1. Fritsch C, Bolsen K, Ruzicka T, Goerz G. (1997) Congenital erythropoietic porphyria. J. Am. Acad. Dermatol. 36:594-610.
2. Anderson KE. (2008) The Porphyrias. In: Goldman L, Ausiello D (eds.) Cecil Medicine. Saunders, Philadelphia, pp. 1585-93.
3. Desnick RJ, Astrin KH. (2002) Congenital erythropoietic porphyria: advances in pathogenesis and treatment. Br. J. Haematol. 117:779-95.
4. Anderson KE, Sassa S, Bishop DF, Desnick RJ. (2001) Disorders of heme biosynthesis: X-Linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) The Metabolic & Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp. 2991-3062.
5. Ged C, Moreau-Gaudry F, Richard E, Robert- Richard E, de Verneuil H. (2009) Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype. Cell. Mol. Biol. (Noisy-le-grand). 55:53-60.
6. de Verneuil H, et al. (1995) [Congenital erythropoietic porphyria. Apropos of a fatal case in the neonatal period due to acute hemolysis with hepatic failure]. Arch. Pediatr. 2:755-61.
7. Fortian A, et al. (2009) Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability. Biochemistry. 48:454-61.
8. Xu W, Astrin KH, Desnick RJ. (1996) Molecular basis of congenital erythropoietic porphyria: mutations in the human uroporphyrinogen III synthase gene. Hum. Mutat. 7:187-92.
9. Kontos AP, Ozog D, Bichakjian C, Lim HW. (2003) Congenital erythropoietic porphyria associated with myelodysplasia presenting in a 72- year-old man: report of a case and review of the literature. Br. J. Dermatol. 148:160-4.
10. Yamauchi K, Kushibiki Y. (1992) Pyridoxal 5-phosphate therapy in a patient with myelodysplastic syndrome and adult onset congenital erythropoietic porphyria. Br. J. Haematol. 81:614-5.
11. Sarkany RP, et al. (2011) Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria. J. Invest. Dermatol. 131:1172-5.
12. Gray CH, Neuberger A, Sneath PH. (1950) Studies in congenital porphyria. 2. Incorporation of 15N in the stercobilin in the normal and in the porphyric. Biochem. J. 47:87-92.
13. Schmid R, Schwartz S, Watson CJ. (1954) Porphyrin content of bone marrow and liver in the various forms of porphyria. AMA Arch. Intern. Med. 93:167-90.
14. Haining RG, Cowger ML, Shurtleff DB, Labbe RF. (1968) Congenital erythropoietic porphyria. I. Case report, special studies and therapy. Am. J. Med. 45:624-37.
15. Anderson KE. (2008) The Porphyrias. In: Cecil Medicine. 23rd edition. Goldman L, Ausiello D (eds.) Saunders Elsevier, Philadelphia, pp. 1585-93.
16. Zix-Kieffer I, et al. (1996) Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease). Bone Marrow Transplant. 18:217-20.
17. Tezcan I, et al. (1998) Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation. Blood. 92:4053-8.
18. Shaw PH, Mancini AJ, McConnell JP, Brown D, Kletzel M. (2001) Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature. Bone Marrow Transplant. 27:101-5.
19. Dupuis-Girod S, et al. (2005) Successful matchunrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Gunther disease). Eur. J. Pediatr. 164:104-7.
20. Benisdhoum M, et al. (1998) The disruption of mouse uroporphyrinogen III Synthase (uros) gene is fully lethal. Transgenomics. 2:275-80.
21. Bishop DF, et al. (2006) Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions. Am. J. Hum. Genet. 78:645-58.
22. Ged C, et al. (2006) A knock-in mouse model of congenital erythropoietic porphyria. Genomics. 87:84-92.
23. Lakso M, et al. (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. U. S. A. 93:5860-5.
24. Tsai SF, Bishop DF, Desnick RJ. (1987) Coupled-enzyme and direct assays for uroporphyrinogen III synthase activity in human erythrocytes and cultured lymphoblasts: enzymatic diagnosis of heterozygotes and homozygotes with congenital erythropoietic porphyria. Anal. Biochem. 166:120-33.
25. Clavero S, et al. (2010) Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations. Hum. Mol. Genet. 19:584-96.
26. Frank J, et al. (1998) C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Ann. Hum. Genet. 62:225-30.
27. Ged C, et al. (1996) Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis. Prenat. Diagn. 16:83-6.
28. Lienhardt A, et al. (1999) A rare cause of fetal ascites: a case report of Gunther's disease. Fetal Diagn. Ther. 14:257-61.
29. Harada FA, Shwayder TA, Desnick RJ, Lim HW. (2001) Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation. J. Am. Acad. Dermatol. 45:279-82.
30. Lazebnik N, Lazebnik RS. (2004) The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein. Prenat. Diagn. 24:282-6.
31. Wiederholt T, et al. (2006) Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria. Physiol. Res. 55 Suppl 2:S85-92.
32. Kitchen H. (1976) Comparative developmental hematology: animal models to study human fetal erythropoiesis. Theriogenology. 6:217-36.
33. Bishop DF, Kitchen H, Wood WA. (1981) Evidence for erythroid and nonerythroid forms of delta-aminolevulinate synthetase. Arch. Biochem. Biophys. 206:380-91.
34. Kaiser IH. (1980) Brown amniotic fluid in congenital erythropoietic porphyria. Obstet. Gynecol. 56:383-4.
35. Thomas C, et al. (1996) Correction of congenital erythropoietic porphyria by bone marrow transplantation. J. Pediatr. 129:453-6.
36. Robert-Richard E, et al. (2008) Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells. Am. J. Hum. Genet. 82:113-24.